Open Access

[Corrigendum] Reactive oxygen species‑mediated activation of the Src‑epidermal growth factor receptor‑Akt signaling cascade prevents bortezomib‑induced apoptosis in hepatocellular carcinoma cells

  • Authors:
    • Jinlin Hou
    • Anguo Cui
    • Peiying Song
    • Hui Hua
    • Ting Luo
    • Yangfu Jiang
  • View Affiliations

  • Published online on: September 8, 2025     https://doi.org/10.3892/mmr.2025.13677
  • Article Number: 312
  • Copyright : © Hou et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Following the publication of the above article, the authors have realized that there were several duplicated western blots featured in Figs. 2‑4. The EGFR blot correctly presented for Fig. 3 (the HepG2 cell line) had been inadvertently featured in Fig. 2 (the EGFR blot for the HepG2 cell line). In Fig. 3, the incorrectly assembled Akt blot for the SMMC‑7721 group was the source image for the correctly presented Akt band in Fig. 1 (the SMMC‑7721 cell line), whereas the Akt blot correctly presented for the Hep3B cell line had been inadvertently featured as the actin blot of the HepG2 cell line. The p‑Src blot correctly presented for Fig. 2 (the SMMC‑7721 cell line) had been inadvertently featured in Fig. 4C (the p‑Src blot for SMMC‑7721). Additionally, the actin blots correctly presented for Fig. 2 (the SMMC‑7721 and HepG2 cell lines) were incorrectly assembled into Fig. 4C (the actin blots for SMMC‑7721 and HepG2). The revised versions of Figs. 2‑4, now showing the correct data for the EGFR blot of the HepG2 cell line in Fig. 2, the Akt blot for the SMMC‑7721 cell line and the actin blot for the HepG2 cell line in Fig. 3, the p‑Src blot for the SMMC‑7721 cell line and the actin blots for SMMC 7721 and HepG2 in Fig. 4C, are shown on the next two pages. The authors wish to state that these errors were made during the figure assembly process, and did not affect either the results or the conclusions reported in this paper. All the authors agree with the publication of this corrigendum, and are grateful to the Editor of Molecular Medicine Reports for granting them the opportunity to publish this. The authors regret that these errors were included in the paper, and also apologize to the readership for any inconvenience caused. [Molecular Medicine Reports 11: 712‑718, 2015; DOI: 10.3892/mmr.2014.2736]

Related Articles

Journal Cover

December-2025
Volume 32 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hou J, Cui A, Song P, Hua H, Luo T and Jiang Y: [Corrigendum] Reactive oxygen species‑mediated activation of the Src‑epidermal growth factor receptor‑Akt signaling cascade prevents bortezomib‑induced apoptosis in hepatocellular carcinoma cells. Mol Med Rep 32: 312, 2025.
APA
Hou, J., Cui, A., Song, P., Hua, H., Luo, T., & Jiang, Y. (2025). [Corrigendum] Reactive oxygen species‑mediated activation of the Src‑epidermal growth factor receptor‑Akt signaling cascade prevents bortezomib‑induced apoptosis in hepatocellular carcinoma cells. Molecular Medicine Reports, 32, 312. https://doi.org/10.3892/mmr.2025.13677
MLA
Hou, J., Cui, A., Song, P., Hua, H., Luo, T., Jiang, Y."[Corrigendum] Reactive oxygen species‑mediated activation of the Src‑epidermal growth factor receptor‑Akt signaling cascade prevents bortezomib‑induced apoptosis in hepatocellular carcinoma cells". Molecular Medicine Reports 32.6 (2025): 312.
Chicago
Hou, J., Cui, A., Song, P., Hua, H., Luo, T., Jiang, Y."[Corrigendum] Reactive oxygen species‑mediated activation of the Src‑epidermal growth factor receptor‑Akt signaling cascade prevents bortezomib‑induced apoptosis in hepatocellular carcinoma cells". Molecular Medicine Reports 32, no. 6 (2025): 312. https://doi.org/10.3892/mmr.2025.13677